Literature DB >> 7615848

The clinical value of urinary cytology: 12 years of experience with 615 patients.

U Maier1, R Simak, N Neuhold.   

Abstract

AIMS: To analyse the diagnostic value of cytological examination compared with histological findings in a large series of patients (n = 615) with tumours of the urinary tract epithelium.
METHODS: Cytological examinations (n = 785) after bladder washing and exfoliative cytology were retrospectively compared and correlated with histological findings. In addition, 1527 bladder washings were obtained during follow up of patients after transurethral resection of bladder tumours.
RESULTS: Cytology in bladder washings (overall diagnostic accuracy 66%) provides considerably more information that exfoliative cytology (overall accuracy 49%). Cytological examinations (n = 1125) in patients with bladder tumours receiving intravesical cytostatic drugs (for example, mitomycin C) yielded suspicious or positive results in 28% of patients, without being confirmed by endoscopy during follow up.
CONCLUSION: Our results illustrate two major drawbacks of urinary cytology. First, a high rate of false positive results in patients on intravesical chemotherapy. Second, a high rate of false negative results in highly differentiated carcinomas, stressing the need for additional diagnostic tests such as staining with monoclonal antibodies directed against tumour antigens or assessment of ploidy.

Entities:  

Mesh:

Year:  1995        PMID: 7615848      PMCID: PMC502547          DOI: 10.1136/jcp.48.4.314

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Cytology in the diagnosis and followup of transitional cell carcinoma of the urothelium: a review with a case series.

Authors:  R W Lewis; A C Jackson; W M Murphy; G A Leblanc; W L Meehan
Journal:  J Urol       Date:  1976-07       Impact factor: 7.450

2.  The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer.

Authors:  R W deVere White; A D Deitch; B West; J M Fitzpatrick
Journal:  J Urol       Date:  1988-02       Impact factor: 7.450

3.  Exfoliative cytology of the urinary bladder irrigation specimen.

Authors:  M J Harris; C P Schwinn; J W Morrow; R L Gray; B M Browell
Journal:  Acta Cytol       Date:  1971 Jul-Aug       Impact factor: 2.319

4.  The morphologic effects of mitomycin C in mammalian urinary bladder.

Authors:  W M Murphy; M S Soloway; W N Crabtree
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

5.  [Value of urothelial dysplasia within the scope of bladder mapping].

Authors:  U Maier; J H Holzner
Journal:  Helv Chir Acta       Date:  1985-09

6.  [Value of urinary cytology in urological diagnosis. Report after ten years (author's transl)].

Authors:  D Jocham; H Göttinger; E Schmiedt
Journal:  Urologe A       Date:  1982-03       Impact factor: 0.639

7.  Grading of transitional cell neoplasms of the urinary bladder from smears of bladder washings. A critical review of 326 tumors.

Authors:  P L Esposti; J Zajicek
Journal:  Acta Cytol       Date:  1972 Nov-Dec       Impact factor: 2.319

8.  The efficacy of urinary cytology in the detection of urothelial tumours. Sensitivity and specificity of urinary cytology.

Authors:  M E Beyer-Boon; H J de Voogt; E A van der Velde; J A Brussee; A Schaberg
Journal:  Urol Res       Date:  1978

9.  Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.

Authors:  G P Hemstreet; S Rollins; P Jones; J Y Rao; R E Hurst; R B Bonner; T Hewett; B G Smith
Journal:  J Urol       Date:  1991-12       Impact factor: 7.450

10.  [Significance of urothelial dysplasia in macroscopically normal mucosa in patients with bladder tumors. Results of a randomized study with and without intravesical mitomycin C in the prevention of recurrence].

Authors:  U Maier; J H Holzner
Journal:  Onkologie       Date:  1985-08
View more
  11 in total

1.  Low utility of CYFRA 21-1 serum levels for diagnosis and follow-up in bladder cancer patients.

Authors:  Daniel Fatela-Cantillo; Antonio Fernández-Suárez; Violeta Menéndez; Juan Antonio Galán; Xavier Filella
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.

Authors:  Mohit Gupta; Niv Milbar; Giorgia Tema; Filippo Pederzoli; Meera Chappidi; Max Kates; Christopher J VandenBussche; Trinity J Bivalacqua
Journal:  World J Urol       Date:  2019-01-23       Impact factor: 4.226

3.  The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.

Authors:  I A Sokolova; K C Halling; R B Jenkins; H M Burkhardt; R G Meyer; S A Seelig; W King
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

4.  Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.

Authors:  P A McKelvie; M Daniell
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

5.  Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness.

Authors:  Bong Gi Ok; Yoon Seob Ji; Young Hwii Ko; Phil Hyun Song
Journal:  Korean J Urol       Date:  2014-10-10

6.  Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up?

Authors:  G Nabi; D Greene; M O O'Donnell; M O Donnel
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

7.  Malignant atypical cell in urine cytology: a diagnostic dilemma.

Authors:  Alka Bhatia; Pranab Dey; Nandita Kakkar; Radhika Srinivasan; Raje Nijhawan
Journal:  Cytojournal       Date:  2006-12-15       Impact factor: 2.091

8.  p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer.

Authors:  H A Phillips; G C Howard; W R Miller
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

9.  The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice.

Authors:  Kyung Won Kwak; Sun Hee Kim; Hyun Moo Lee
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

10.  Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer.

Authors:  Alexis Rivas; Verónica Burzio; Eduardo Landerer; Vincenzo Borgna; Sebastian Gatica; Rodolfo Ávila; Constanza López; Claudio Villota; Rodrigo de la Fuente; Javiera Echenique; Luis O Burzio; Jaime Villegas
Journal:  BMC Urol       Date:  2012-12-18       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.